Verification register Bio, Health & Neuro
Current reading
Readiness band and full integer triple
AI-assisted assembly · derived results
Readiness band
Emerging
Primary summary from verified readiness
- Confidence
- 68% · stale
- Computed at
- 2026-08-20T10:53:39.490184+00:00
- Claimed
- 40
- Reported
- 35
- Verified
- 31
- Gap
- +9
Public ambition and stated capability
Observed practitioner reporting
Independently supported evidence
Claimed leads verified
Evidence strength Strong
Decision
What the current evidence supports
Human editorial judgment · 2026-08-20
Too early to adopt
- Why
- This is the first in vivo prime-editing CTA clearance — a notable platform milestone — but there is zero human data, a constrained cash runway, and single-mutation scope, so it is a watch-list item, not an adoptable capability.
- Next
- Wait for the first-in-human safety/biological-activity readout in 2027 (copper efflux via 64Cu PET, ceruloplasmin, urinary copper) before treating in vivo prime editing as clinically de-risked.
Constraints
Blockers
No named blocker is present in the current public projection.
Evidence summary
Derived counts
AI-assisted assembly
- Total
- 11
- Tier 1
- 0
- Tier 2
- 4
- Tier 3
- 7
- Supports
- 1
- Contradicts
- 4
- Context
- 6
- Latest observed
- 2026-07-20
Counts and dates only. Raw signals, private excerpts, trust records, and internal corpus material are not published here.
Publication record
Revisions
Initial public reading
- 2026-07-19 Reading moved from emerging to emerging.